(Jerusalem Post) Maayan Jaffe-Hoffman - The Relivion migraine system, an Israeli headband that transmits electrical signals and stops migraine pain, has been approved by the European Commission for pharmaceuticals. The brain neuromodulation device is geared toward helping individuals who suffer from a range of neurological and neuropsychiatric disorders, including migraine headaches. The band is connected to a cellphone application directed by the patient. It sends signals to the brain, creating "neuromodulation," which blocks the nerve signals that cause the pain. Over time, the system "learns" the optimal treatment for each specific patient. It is the first device of its kind considered safe for outpatient use.
2019-07-18 00:00:00Full ArticleBACK Visit the Daily Alert Archive